provider
Search result for "Solr search content"
Search Result for "Melanoma"
provider
Jane Mattei, MD, PhD Hematology Oncology, Melanoma Medical Oncology
Clinical Trial
S2015 Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (CTMS# 23-0072)
The primary objective of the trial is to assess whether there is no difference in disease-free survival for patients treated with a 1cm excision margin when compared to a 2cm margin for stage II primary melanomas (AJCC 8th edition; pT2b-pT4b).
Cancer Type
Melanoma
Cancer Type
Ocular Melanoma
Research & Publications
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
Research & Publications
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Research & Publications